10.03.2025: SCQM in transition: future secured through restructuring and strategic reorientation
The SCQM Foundation has faced growing financial challenges in recent years. To maintain the long-term stability and financial sustainability of the foundation, a significant restructuring was necessary.
Through a strategic realignment of our resources, we are now looking confidently to the future. We have secured both the operation of our facility with the availability of data and the continuation of our core services. Ongoing and planned research projects will continue. We will also always remain true to our vision: ‘Together with applicable data to better treatments for rheumatic diseases’.
The management will now be taken over by a co-management team consisting of Dr Catherine Raptis (Science & Partnerships) and Isabelle Burger (Data Management & Communication). We would like to express our sincere thanks to our previous managing director, Dr Judith Safford, for her dedicated and valuable work. We wish her all the best for her well-deserved retirement.
At the same time, we regret that some valued employees are leaving the foundation as a result of the restructuring. We would like to thank them warmly for their great commitment and valuable work, which has contributed significantly to the development and success of the SCQM Foundation.
We would like to take this opportunity to thank you for your continued trust and commitment. You are making a valuable contribution to rheumatism research and quality management.
If you have any questions or require further information, please do not hesitate to contact us.
09.12.2024: SCQM webinar from 24 October to view
We are happy to share with you the webinar at which renowned experts gave exciting presentations on studies with SCQM data and other topics. This webinar was launched for healthcare professionals and partners.
Obesity – an increasing health problem in axSpA (PD Dr. med. Raphael Micheroli)
COMPASS – Promoting self-management in the doctor's office (Isabelle Steeb)
Advantages and challenges of the SCQM patient registry in everyday practice (Chrysoula Manolaraki, MD)
Prescription restrictions for TNFi therapy in PsA – useful or not? (Burkhard Möller, MD, PhD)
26.03.2024: New regulation regarding biosimilars
Measures to promote generics and biosimilars came into force on January 1, 2024. The Swiss Rheumatism League explains the changes that you should know about as a patient. Pharmacists are now allowed to replace an original biological medicine prescribed by a doctor with an available, cheaper biosimilar. Important: If this is the case for you and the medication in mySCQM is no longer up to date, please inform your doctor. Alternatively, you can also contact the SCQM office so that your medication can be entered correctly in the SCQM database again. In this way, you will help to maintain the integrity of the SCQM data - thank you very much for your valuable contribution!
23.08.2023: The practical benefits of the SCQM patient registry for affected persons
On the occasion of the Swiss Axial Spondyloarthritis Meeting 2023, Dr Judith Safford, Executive Director of the SCQM Fondation and member of the Swiss Axial Spondyloarthritis Association, gave a video presentation. She spoke about the importance and benefits of the patient registry and about current challenges in the health care system.
You can find the whole presentation on bechterew.ch
19.04.2023: The new brochure for patients
Just in time for the go live of the new website, the new brochure for patients is available (in German, in French, in Italian). It is intended to provide patients with a basis for deciding to make their data available to research and thus make an important contribution to research and quality management.
We hope you enjoy reading it.